Form D — Invirsa, Inc.
0001836108-25-000002 · filed Aug 6, 2025
Figures are issuer-reported and describe stored filings. Data coverage and methodology.
Check this disclosure on SEC EDGAR · More Pharmaceuticals filings
Offering
- Industry
- Pharmaceuticals
- Exemptions
- Rule 506(b)
- Reported offering amount
- $2,832,000
- Reported amount sold
- $2,832,000
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Invirsa, Inc.
- CIK
- 1836108
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- —
- Address
- 1275 KINNEAR ROAD
COLUMBUS, Ohio 43212 - Phone
- 614-715-1860
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Robert Shalwitz · Executive OfficerColumbus, Ohio Find on LinkedIn ↗
-
Rachael Wingo · Executive OfficerColumbus, Ohio Find on LinkedIn ↗
-
Wayne Embree · DirectorColumbus, Ohio Find on LinkedIn ↗
-
Faith Voinovich · DirectorColumbus, Ohio Find on LinkedIn ↗
-
Tim Willis · DirectorColumbus, Ohio Find on LinkedIn ↗
Other filings from this issuer
View the original filing on SEC EDGAR ↗